ENTA
Enanta Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +22.2% ·
share flow +7.2% ·
net new positions +18.2%
· formula
Broad accumulation: rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 11.84K | $143,216 | n/a | n/a |
| Q2 2026 | 56 | -3 | 10.74M | $156.55M | +2 | −5 |
| Q1 2026 | 62 | -2 | 14.86M | $187.69M | +5 | −7 |
| Q4 2025 | 64 | +3 | 16.10M | $253.79M | +3 | n/a |
| Q3 2025 | 16 | +1 | 7.96M | $95.31M | +2 | −1 |
| Q2 2025 | 12 | 0 | 8.38M | $63.38M | n/a | n/a |
| Q1 2025 | 9 | -2 | 4.49M | $24.81M | n/a | −2 |
| Q4 2024 | 11 | -1 | 4.05M | $23.26M | n/a | −1 |
| Q3 2024 | 11 | +2 | 4.15M | $43.00M | +2 | n/a |
| Q2 2024 | 9 | n/a | 3.87M | $50.19M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Marshall Wace ✦ | 850.89K | -8.3% | $8.82M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Millennium Management ✦ | 731.29K | +7.0% | $7.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 672.88K | +44.6% | $6.97M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Renaissance Technologies ✦ | 524.90K | +2.7% | $5.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 501.37K | -6.1% | $5.19M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 6 | Geode Capital Management ✦ (passive) | 477.35K | +3.1% | $4.95M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 7 | Two Sigma Investments ✦ | 191.26K | +3.6% | $1.98M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 87.19K | New | $903,288 | 0.0% | New | 1 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 40.70K | 0.0% | $421,652 | 0.0% | Held | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 37.86K | -36.9% | $392,219 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 11 | Wellington Management ✦ | 34.75K | New | $360,020 | 0.0% | New | 1 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $903,288 | 0.0% |
| Wellington Management | $360,020 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 131 holders, 26.72M shares, $290.62M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.